These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 4308440
1. [Resistance of tubercle bacilli to cycloserine, viomycin and ethionamide in patients suffering from pulmonary tuberculosis]. Srednicka-Zajac D, Mysakowska H, Szarewicz-Adamczyk W, Litwin B. Ann Univ Mariae Curie Sklodowska Med; 1967; 22():71-8. PubMed ID: 4308440 [No Abstract] [Full Text] [Related]
3. [Evolution of antibiograms of bacilli persisting under treatment in the sanatorium]. Marion L. Rev Tuberc Pneumol (Paris); 1967; 31(6):785-808. PubMed ID: 4317451 [No Abstract] [Full Text] [Related]
4. Cycloserine plus ethionamide plus pyrazinamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy. Ramakrishnan CV, Parthasarathy R, Sambamoorthy S, Somasundaram PR, Subbammal S. Indian J Med Res; 1976 Jan; 64(1):76-82. PubMed ID: 818010 [No Abstract] [Full Text] [Related]
5. [Treatment of chronic destructive forms of pulmonary tuberculosis with drugs of the second series in different combinations]. Mamolat AS, Bialik IB. Probl Tuberk; 1969 Jan; 47(6):23-8. PubMed ID: 4311969 [No Abstract] [Full Text] [Related]
11. [Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests]. Tsukamura M. Kekkaku; 1971 Oct; 46(10):405-8. PubMed ID: 4112456 [No Abstract] [Full Text] [Related]
12. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs. Oka S, Motomiya M, Kato S, Sato H, Fujimoto M. Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):91-3. PubMed ID: 4968094 [No Abstract] [Full Text] [Related]
13. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs]. Matsumoto M, Izumi K, Kamima H, Hirose H, Saito M. Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711 [No Abstract] [Full Text] [Related]
14. The results of treatment in patients with cultures resistant to streptomycin, isoniazid and PAS: a five-year follow-up. Tousek J, Jancik E, Zelenka M, Jancikova-Máková M. Tubercle; 1967 Mar; 48(1):27-31. PubMed ID: 4291925 [No Abstract] [Full Text] [Related]
15. [Bacteriostatic activity of preparations of the 2d series and criteria of the resistance to them]. Mkrtchian SV, Afanas'eva IuP. Probl Tuberk; 1967 Mar; 45(8):70-5. PubMed ID: 4303640 [No Abstract] [Full Text] [Related]
17. [Secondary antitubercular drugs in the treatment of childhood tuberculosis]. de Lacerda A. Rev Port Pediatr Pueric; 1967 May; 30(5):149-56. PubMed ID: 4303078 [No Abstract] [Full Text] [Related]
18. Newer and second-line drugs in the treatment of drug-resistant tuberculosis in children. Steiner M. Med Clin North Am; 1967 Sep; 51(5):1153-67. PubMed ID: 4297572 [No Abstract] [Full Text] [Related]
19. [Treatment with new antitubercular agents]. Gartmann J. Dtsch Med Wochenschr; 1968 Nov 22; 93(47):2281-2. PubMed ID: 4301079 [No Abstract] [Full Text] [Related]
20. [Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital]. Sirota DS, Man'kovetskiĭ EF, Koĭfman SG, Vatsyk MZ. Probl Tuberk; 1974 Nov 22; (10):17-9. PubMed ID: 4370967 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]